TABLE 1.
Baseline clinical characteristics of the study patients
| Total (n = 101) | DM(−) | DM(+) | P value | |
|---|---|---|---|---|
| (n = 67) | (n = 34) | |||
| Age (year) | 53.54 ± 4.64 | 54.21 ± 4.36 | 52.21 ± 4.93 | 0.052 |
| Male (%) | 62(61.4) | 42(62.7) | 20(58.8) | 0.829 |
| BMI (kg/m2) | 24.12 ± 1.42 | 24.12 ± 1.45 | 24.10 ± 1.37 | 0.963 |
| Smoking history (%) | 38 (37.6) | 27 (40.3) | 11(32.4) | 0.517 |
| Mean heart rate/24 h (bpm) | 69.56 ± 9.93 | 70.21 ± 9.15 | 68.29 ± 11.34 | 0.314 |
| CRE (μmol/L) | 60.60 ± 7.30 | 61.12 ± 7.06 | 59.56 ± 7.77 | 0.291 |
| UA (μmol/L) | 282.75 ± 41.31 | 288.16 ± 43.18 | 272.09 ± 35.58 | 0.071 |
| ALT (U/L) | 26.84 ± 11.11 | 27.53 ± 11.40 | 25.47 ± 10.55 | 0.495 |
| AST (U/L) | 81.39 ± 14.97 | 80.69 ± 13.98 | 82.76 ± 16.88 | 0.490 |
| LDL (mmol/L) | 1.98 ± 0.74 | 2.08 ± 0.74 | 1.78 ± 0.73 | 0.097 |
| K+ (mmol/L) | 4.26 ± 0.31 | 4.25 ± 0.33 | 4.29 ± 0.26 | 0.433 |
| Na+(mmol/L) | 138.10 ± 2.50 | 138.01 ± 2.30 | 138.26 ± 2.90 | 0.977 |
| Troponin I (ng/mL) | 5.36 ± 3.31 | 5.20 ± 3.02 | 5.67 ± 3.85 | 0.736 |
| QTc interval (ms) | 426.42 ± 11.26 | 426.51 ± 10.47 | 426.24 ± 12.84 | 0.838 |
| HbA1c (%) | 6.15 ± 2.00 | 5.10 ± 0.96 | 8.20 ± 1.92 | <0.001 |
| LVEF (%) | 40.64 ± 3.20 | 41.40 ± 2.74 | 39.15 ± 3.93 | <0.001 |
ALT, glutamic‐pyruvic transaminase; AST, glutamic‐oxalacetic transaminease; BMI, body mass index; CRE, creatinine; HbA1c, glycated haemoglobin; LDL, low density lipoprotein; UA, uric acid; PVCs, premature ventricular contractions.
Continuous variables are presented as mean ± SD; categorical variables are presented as numbers or percentages.